• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重后心血管事件:意大利 COPD 加重及其心血管疾病结局研究的结果。

Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy.

机构信息

Fondazione Ricerca e Salute (ReS) - Research and Health Foundation, Rome, Italy.

Fondazione Ricerca e Salute (ReS) - Research and Health Foundation, Rome, Italy.

出版信息

Eur J Intern Med. 2024 Sep;127:97-104. doi: 10.1016/j.ejim.2024.04.021. Epub 2024 May 9.

DOI:10.1016/j.ejim.2024.04.021
PMID:38729787
Abstract

INTRODUCTION

Exacerbations of chronic obstructive pulmonary disease (COPD) can increase the risk of severe cardiovascular events.

OBJECTIVE

Assess the crude incidence rates (IR) of cardiovascular events and the impact of exacerbations on the risk of cardiovascular events within different time periods following an exacerbation.

METHODS

COPD patients aged ≥45 years between 01/01/2015 and 12/31/2018 were identified from the Fondazione Ricerca e Salute administrative database. IRs of severe non-fatal and fatal cardiovascular events were obtained for post-exacerbation time periods (1-7, 8-14, 15-30, 31-180, 181-365 days). Time-dependent Cox proportional hazard models compared cardiovascular risks between periods with and without exacerbations.

RESULTS

Of 216,864 COPD patients, >55 % were male, mean age was 74 years, frequent comorbidities were cardiovascular, metabolic and psychiatric. During an average 34-month follow-up, 69,620 (32 %) patients had ≥1 exacerbation and 46,214 (21 %) experienced ≥1 cardiovascular event. During follow-up, 55,470 patients died; 4,661 were in-hospital cardiovascular-related deaths. Among 10,269 patients experiencing cardiovascular events within 365 days post-exacerbation, the IR was 15.8 per 100 person-years (95 %CI 15.5-16.1). Estimated hazard ratios (HR) for the cardiovascular event risk associated with periods post-exacerbation were highest within 7 days (HR: 34.3, 95 %CI: 33.1-35.6), especially for heart failure (HR 50.6; 95 %CI 48.6-52.7) and remained elevated throughout 365 days (HR 1.1, 95 %CI 1.02-1.13).

CONCLUSIONS

COPD patients in Italy are at high risk of severe cardiovascular events following exacerbations, suggesting the need to prevent exacerbations and possible subsequent cardiovascular events through early interventions and treatment optimization.

摘要

简介

慢性阻塞性肺疾病(COPD)的加重会增加发生严重心血管事件的风险。

目的

评估心血管事件的粗发生率(IR)以及在加重后不同时间段内加重对心血管事件风险的影响。

方法

从 Fondazione Ricerca e Salute 管理数据库中确定了 2015 年 1 月 1 日至 2018 年 12 月 31 日期间年龄≥45 岁的 COPD 患者。为加重后时间段(1-7、8-14、15-30、31-180、181-365 天)获得严重非致命性和致命性心血管事件的 IR。时间依赖性 Cox 比例风险模型比较了有无加重的时间段之间的心血管风险。

结果

在 216864 例 COPD 患者中,超过 55%为男性,平均年龄为 74 岁,常见合并症有心血管、代谢和精神疾病。在平均 34 个月的随访中,69620(32%)例患者有≥1 次加重,46214(21%)例患者有≥1 次心血管事件。随访期间,55470 例患者死亡;4661 例为住院心血管相关死亡。在 10269 例在加重后 365 天内发生心血管事件的患者中,IR 为 15.8/100 人年(95%CI 15.5-16.1)。与加重后时间段相关的心血管事件风险的估计风险比(HR)在 7 天内最高(HR:34.3,95%CI:33.1-35.6),尤其是心力衰竭(HR 50.6;95%CI 48.6-52.7),并在 365 天内持续升高(HR 1.1,95%CI 1.02-1.13)。

结论

意大利的 COPD 患者在加重后发生严重心血管事件的风险很高,这表明需要通过早期干预和治疗优化来预防加重和可能随后发生的心血管事件。

相似文献

1
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy.慢性阻塞性肺疾病急性加重后心血管事件:意大利 COPD 加重及其心血管疾病结局研究的结果。
Eur J Intern Med. 2024 Sep;127:97-104. doi: 10.1016/j.ejim.2024.04.021. Epub 2024 May 9.
2
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.慢性阻塞性肺疾病加重后发生严重心血管事件的风险增加:日本 EXACOS-CV 研究结果。
Adv Ther. 2024 Aug;41(8):3362-3377. doi: 10.1007/s12325-024-02920-y. Epub 2024 Jul 8.
3
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后长期心血管风险增加。
Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487.
4
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.慢性阻塞性肺疾病加重增加后续心血管事件风险:COPDGene 研究的纵向分析。
J Am Heart Assoc. 2024 Jun 4;13(11):e033882. doi: 10.1161/JAHA.123.033882. Epub 2024 May 31.
5
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.慢性阻塞性肺疾病加重后心血管事件的风险:利用荷兰 PHARMO 数据网络的 EXACOS-CV 队列研究结果。
Respir Res. 2023 Nov 21;24(1):293. doi: 10.1186/s12931-023-02601-4.
6
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险:一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
7
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.慢性阻塞性肺疾病患者加重后心血管事件的时间依赖性风险:来自 IMPACT 试验的事后分析。
J Am Heart Assoc. 2022 Sep 20;11(18):e024350. doi: 10.1161/JAHA.121.024350. Epub 2022 Sep 14.
8
Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.COPD 稳定合并心血管疾病患者的加重与严重心血管事件相关:一项全国性基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 1;18:419-429. doi: 10.2147/COPD.S396790. eCollection 2023.
9
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.COPD 急性加重后死亡和心血管事件的风险:EXACOS-CV 美国研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jan 18;19:225-241. doi: 10.2147/COPD.S438893. eCollection 2024.
10
Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.成人非心血管危险因素慢性阻塞性肺疾病加重率的季节性和区域性差异。
Ann Am Thorac Soc. 2018 Nov;15(11):1296-1303. doi: 10.1513/AnnalsATS.201801-070OC.

引用本文的文献

1
Impact of influenza on chronic obstructive pulmonary disease: pathophysiology, exacerbations, and preventive approaches.流感对慢性阻塞性肺疾病的影响:病理生理学、急性加重及预防方法。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251363307. doi: 10.1177/17534666251363307. Epub 2025 Sep 9.
2
Prevalence and Risk Factors of Arrhythmias in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病急性加重患者心律失常的患病率及危险因素:一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 Sep 3;20:3059-3072. doi: 10.2147/COPD.S545658. eCollection 2025.
3
The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies.
慢性阻塞性肺疾病急性加重后心血管风险的持续增加:EXACOS-CV研究的荟萃分析
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.01091-2024. eCollection 2025 May.
4
Relationships between vitamin C intake and COPD assessed by machine learning approaches from the NHANES (2017-2023).通过机器学习方法对美国国家健康与营养检查调查(2017 - 2023年)数据评估维生素C摄入量与慢性阻塞性肺疾病之间的关系。
Front Nutr. 2025 May 15;12:1563692. doi: 10.3389/fnut.2025.1563692. eCollection 2025.
5
Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study.西班牙接受布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病患者的特征:AURA研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 9;20:999-1008. doi: 10.2147/COPD.S490227. eCollection 2025.
6
Does a Raised Serum Troponin During a Severe Chronic Obstructive Pulmonary Disease Exacerbation Predict Future Cardiovascular Events?严重慢性阻塞性肺疾病急性加重期血清肌钙蛋白升高是否预示未来心血管事件?
Cureus. 2025 Feb 19;17(2):e79288. doi: 10.7759/cureus.79288. eCollection 2025 Feb.